Novel needle‐type electrocoagulation and combination pharmacotherapy: Basic and clinical studies on efficacy and safety in treating keloids
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Jingting Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Keloid, Mice, Nude, Electrocoagulation, Fluorouracil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Nantong Municipality.
Abstract (Originalsprache)
Background and Aim Keloids cannot be effectively treated using monotherapy regimens. This study aimed to evaluate the efficacy and safety of ablation (a novel needle‐assisted electrocoagulation technique) combined with pharmacotherapy (corticosteroid and 5‐fluorouracil [5‐FU] injections) in removing keloids and to investigate the underlying biological mechanisms.
Methods
The effects of energy consumption and duration of needle‐assisted electrocoagulation on the ablation zone were tested in porcine liver tissue, which simulates human skin. The regulatory effects of ablation combined with pharmacotherapy on collagen deposition, cell proliferation, and angiogenesis were analyzed in a keloid‐bearing nude mouse model in vivo. In a clinical trial involving six patients with keloids, the Vancouver Scar Scale (VSS) and Patient and Observer Scar Assessment Scale (POSAS) scores were graded before treatment and 1 month after one cycle of ablation combined with corticosteroid and 5‐FU therapy.
Results
Higher energy consumption and longer duration of electrocoagulation resulted in a larger ablation zone and higher surface temperature. Ablation combined with pharmacotherapy significantly reduced keloid volume in nude mice, upregulated MMP‐1 and MMP‐3, downregulated COL I and COL III, and inhibited angiogenesis and proliferation. This combination also significantly reduced the VSS and POSAS scores in patients with keloids after treatment without any obvious adverse events.
Conclusion
Our findings show that electroablation combined with pharmacotherapy effectively reduces keloid volume by inhibiting collagen deposition, angiogenesis, and cell proliferation. Thus, this novel combination may serve as a safe therapeutic approach for keloid removal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China.
- Medical School of Nantong University, Nantong, China.
- Nantong Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China.
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Förderung
- Natural Science Foundation of Nantong Municipality
Zitieren
APA
Zhao, J., Zhai, X., Xu, Z., Zhou, S., Gu, L., Chen, L., Zhou, B., & Hua, H. (2024). Novel needle‐type electrocoagulation and combination pharmacotherapy: Basic and clinical studies on efficacy and safety in treating keloids. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16453
Vancouver
Zhao J, Zhai X, Xu Z, Zhou S, Gu L, Chen L, et al. Novel needle‐type electrocoagulation and combination pharmacotherapy: Basic and clinical studies on efficacy and safety in treating keloids. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16453
BibTeX
@article{Zhao2024,
author = {Zhao, Jingting and Zhai, Xiaoyu and Xu, Zhiyi and Zhou, Shu and Gu, Liqun and Chen, Lin and Zhou, Bingrong and Hua, Hui},
title = {Novel needle‐type electrocoagulation and combination pharmacotherapy: Basic and clinical studies on efficacy and safety in treating keloids},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16453}
}
EUVIMED